Sone-040 Jun 2026
Traditional immunotherapies often struggle to reach the tumor without causing severe side effects throughout the rest of the body. SONE-040 solves this using Sonnet’s proprietary technology.
- Printed by Atlassian Confluence 9.2.12
Commons contains user-contributed content and
does not represent the position or endorsement of the Laboratory, DOE,
or the University of California. Your use of this site is subject to
our security and privacy policies.
Questions & Comments Privacy & Security Notice
A U.S. Department of Energy National Laboratory Operated by the University of California
Questions & Comments Privacy & Security Notice